Citations

Showing 10 of 108094 citations.

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis
Milani, Paolo , Perlini, Stefano , Mussinelli, Roberta , Lacy, Martha Q. , Kumar, Shaji , Merlini, Giampaolo , Hayman, Suzanne R. , Dingli, David , Klarich, Kyle W. , Lust, John A., Lin, Yi , Kapoor, Prashant , Pellikka, Patricia A. , Hwa, Yi L. , Zeldenrust, Stephen R., Kyle, Robert A. , Grogan, Martha , Merlini, Giampaolo , Milani, Paolo , Pellikka, Patricia A , Dingli, David , Lin, Yi , Dispenzieri, Angela , Scott, Christopher G. , Gertz, Morie A. , Buadi, Francis K. , Maurer, Matthew J. , Leung, Nelson , Go, Ronald S. , Rajkumar, S. Vincent , Mussinelli, Roberta , Perlini, Stefano

Mayo Clinic

Circulation: Cardiovascular Imaging | May 11, 2018 | Volume: 11 | Issue: 5 | Pages: No page available

10.1161/circimaging.117.006588 | PMID 29752392 Get It

Background: Heart involvement is the most important prognostic determinant in AL amyloidosis patients. Echocardiography is a cornerstone for the diagnosis and provides important prognostic information. Methods and Results: We studied 754 patients with AL amyloidosis who underwent echocardiographic assessment at the Mayo Clinic, including a Doppler-derived measurement of stroke volume (SV) within 30 days of their diagnosis to explore the prognostic role of echocardiographic variables in the context of a well-established soluble cardiac biomarker staging system. Reproducibility of SV, myocardial contraction fraction, and left ventricular strain was assessed in a separate, yet comparable, study cohort of 150 patients from the Pavia Amyloidosis Center. The echocardiographic measures most predictive for overall survival were SV index <33 mL/min, myocardial contraction fraction <34%, and cardiac index <2.4 L/min/m 2 with respective hazard ratios (95% confidence intervals) of 2.95 (2.37–3.66), 2.36 (1.96–2.85), and 2.32 (1.91–2.80). For the subset that had left ventricular strain performed, the prognostic cut point was −14% (hazard ratios, 2.70; 95% confidence intervals, 1.84–3.96). Each parameter was independent of systolic blood pressure, Mayo staging system (NT-proBNP [N-terminal pro-B-type natriuretic peptide] and troponin), and ejection fraction on multivariable analysis. Simple predictive models for survival, including biomarker staging along with SV index or left ventricular strain, were generated. Conclusions: SV index prognostic performance was similar to left ventricular strain in predicting survival in AL amyloidosis, independently of biomarker staging. Because SV index is routinely calculated and widely available, it could serve as the preferred echocardiographic measure to predict outcomes in AL amyloidosis patients.
Functional Invalidation of Putative Sudden Infant Death Syndrome–Associated Variants in the KCNH2 -Encoded Kv11.1 Channel
Tester, David J. , Hall, Allison R., Burgess, Don E. , Hsu, Chun‐Chun , Elayi, Samy Claude, Anderson, Corey L. , January, Craig T., Luo, Jonathan Z. , Hartzel, Dustin N. , Murray, Michael F. , Ackerman, Michael J. , Delisle, Brian P. , Smith, Jennifer L. , Mirshahi, Uyenlinh L. , Mirshahi, Tooraj

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | May 11, 2018 | Volume: 11 | Issue: 5 | Pages: No page available

10.1161/circep.117.005859 | PMID 29752375 Get It

Background: Heterologous functional validation studies of putative long-QT syndrome subtype 2–associated variants clarify their pathological potential and identify disease mechanism(s) for most variants studied. The purpose of this study is to clarify the pathological potential for rare nonsynonymous KCNH2 variants seemingly associated with sudden infant death syndrome. Methods: Genetic testing of 292 sudden infant death syndrome cases identified 9 KCNH2 variants: E90K, R181Q, A190T, G294V, R791W, P967L, R1005W, R1047L, and Q1068R. Previous studies show R181Q-, P967L-, and R1047L-Kv11.1 channels function similar to wild-type Kv11.1 channels, whereas Q1068R-Kv11.1 channels accelerate inactivation gating. We studied the biochemical and biophysical properties for E90K-, G294V-, R791W-, and R1005W-Kv11.1 channels expressed in human embryonic kidney 293 cells; examined the electronic health records of patients who were genotype positive for the sudden infant death syndrome–linked KCNH2 variants; and simulated their functional impact using computational models of the human ventricular action potential. RESULTS: Western blot and voltage-clamping analyses of cells expressing E90K-, G294V-, R791W-, and R1005W-Kv11.1 channels demonstrated these variants express and generate peak Kv11.1 current levels similar to cells expressing wild-type-Kv11.1 channels, but R791W- and R1005W-Kv11.1 channels accelerated deactivation and activation gating, respectively. Electronic health records of patients with the sudden infant death syndrome–linked KCNH2 variants showed that the patients had median heart rate–corrected QT intervals <480 ms and none had been diagnosed with long-QT syndrome or experienced cardiac arrest. Simulating the impact of dysfunctional gating variants predicted that they have little impact on ventricular action potential duration. Conclusions: We conclude that these rare Kv11.1 missense variants are not long-QT syndrome subtype 2–causative variants and therefore do not represent the pathogenic substrate for sudden infant death syndrome in the variant-positive infants.
Frequently rearranged and overexpressed δ-catenin is responsible for low sensitivity of prostate cancer cells to androgen receptor and β-catenin antagonists
Zhang, Piyan , Schaefer-Klein, Janet, Cheville, John C. , Vasmatzis, George , Kovtun, Irina V.

Mayo Clinic

Oncotarget | May 11, 2018 | Volume: 9 | Issue: 36 | Pages: 24428-24442

10.18632/oncotarget.25319 | PMID 29849951 Get It

The impact of obesity on perceived patient‐centred communication
Phelan, Sean M. , Lynch, Brian , Blake, Kelly D. , Blanch‐Hartigan, Danielle , Wilson, Patrick M. , Phelan, S M , Hardeman, Rachel R. , Branda, Megan E. , Rutten, Lila J. Finney

Mayo Clinic

Obesity Science & Practice | May 11, 2018 | Volume: 4 | Issue: 4 | Pages: 338-346

10.1002/osp4.276 | PMID 30151228 Get It

Summary Objective Patient–provider communication has been found to be less patient centred, on average, with patients who are members of stigmatized or minority groups. Obesity is a stigmatized condition, and thus, people with obesity may experience less patient‐centred communication (PCC). The objective of this study was to assess the association between patient body mass index (BMI) and self‐reported quality of PCC experienced over a 12‐month period and whether that relationship differed for men and women. Methods Data collected for the National Cancer Institute's Health Information National Trends Survey were analysed. Respondents who reported a BMI ≥ 18.5 kg/m 2 and indicated having seen a healthcare provider outside of an emergency room in the last 12 months were included. PCC was measured using a validated six‐item scale. Multivariate logistic regression was used to model the odds of reporting PCC greater than the sample median. Results Compared with people with normal weight BMIs, no associations were found between overweight (odds ratio [OR] = 0.84, p = 0.17), class I & II obesity (OR = 0.94, p = 0.68) or class III obesity (OR = 0.86, p = 0.47) and PCC. There was a significant interaction ( p = 0.015) such that for men, but not women, higher BMI was associated with less PCC. Conclusion Unlike evidence that women experience more weight stigma, in the healthcare domain, men may be at elevated risk of experiencing communication influenced by weight stigma.
Evaluation of projection‐ and dual‐energy‐based methods for metal artifact reduction in CT using a phantom study
Long, Zaiyang , Bruesewitz, Michael R. , Amrami, Kimberly K. , Adkins, Mark C., Glazebrook, Katrina N. , Kofler, James M., Halaweish, Ahmed F., Yu, Lifeng , DeLone, David R. , Morris, Jonathan M. , Leng, Shuai , McCollough, Cynthia H. , Fletcher, Joel G. , Yu, Lifeng

Mayo Clinic

Journal of Applied Clinical Medical Physics | May 11, 2018 | Volume: 19 | Issue: 4 | Pages: 252-260

10.1002/acm2.12347 | PMID 29749048 Get It

AbstractObjectivesBoth projection and dual‐energy (DE)‐based methods have been used for metal artifact reduction (MAR) in CT. The two methods can also be combined. The purpose of this work was to evaluate these three MAR methods using phantom experiments for five types of metal implants.Materials and MethodsFive phantoms representing spine, dental, hip, shoulder, and knee were constructed with metal implants. These phantoms were scanned using both single‐energy (SE) and DE protocols with matched radiation output. The SE data were processed using a projection‐based MAR (iMAR, Siemens) algorithm, while the DE data were processed to generate virtual monochromatic images at high keV (Mono+, Siemens). In addition, the DE images after iMAR were used to generate Mono+ images (DE iMAR Mono+). Artifacts were quantitatively evaluated using CT numbers at different regions of interest. Iodine contrast‐to‐noise ratio (CNR) was evaluated in the spine phantom. Three musculoskeletal radiologists and two neuro‐radiologists independently ranked the artifact reduction.ResultsThe DE Mono+ at high keV resulted in reduced artifacts but also lower iodine CNR. The iMAR method alone caused missing tissue artifacts in dental phantom. DE iMAR Mono+ caused wrong CT numbers in close proximity to the metal prostheses in knee and hip phantoms. All musculoskeletal radiologists ranked SE iMAR > DE iMAR Mono+ > DE Mono+ for knee and hip, while DE iMAR Mono+ > SE iMAR > DE Mono+ for shoulder. Both neuro‐radiologists ranked DE iMAR Mono+ > DE Mono+ > SE iMAR for spine and DE Mono+ > DE iMAR Mono+ > SE iMAR for dental.ConclusionsThe SE iMAR was the best choice for the hip and knee prostheses, while DE Mono+ at high keV was best for dental implants and DE iMAR Mono+ was best for spine and shoulder prostheses. Artifacts were also introduced by MAR algorithms.
Biomaterial characterization of off-the-shelf decellularized porcine pericardial tissue for use in prosthetic valvular applications
Choe, Joshua A. , Jana, Soumen , Tefft, Brandon J. , Hennessy, Ryan S., Go, Jason L. , Morse, David , Go, Jason, Young, Melissa D , Morse, David , Lerman, Amir

Mayo Clinic

Journal of Tissue Engineering and Regenerative Medicine | May 11, 2018 | Volume: 12 | Issue: 7 | Pages: 1608-1620

10.1002/term.2686 | PMID 29749108 Get It

Pitch imperfect
Li, Shuai

Mayo Clinic

Science | May 10, 2018 | Volume: 360 | Issue: 6389 | Pages: 678-678

10.1126/science.360.6389.678 | PMID 29748287 Get It

Propensity Score Methods: Theory and Practice for Anesthesia Research
Schulte, Phillip J. , Mascha, Edward J.

Mayo Clinic

Anesthesia & Analgesia | May 10, 2018 | Volume: 127 | Issue: 4 | Pages: 1074-1084

10.1213/ane.0000000000002920 | PMID 29750691 Get It

Observational data are often readily available or less costly to obtain than conducting a randomized controlled trial. With observational data, investigators may statistically evaluate the relationship between a treatment or therapy and outcomes. However, inherent in observational data is the potential for confounding arising from the nonrandom assignment of treatment. In this statistical grand rounds, we describe the use of propensity score methods (ie, using the probability of receiving treatment given covariates) to reduce bias due to measured confounders in anesthesia and perioperative medicine research. We provide a description of the theory and background appropriate for the anesthesia researcher and describe statistical assumptions that should be assessed in the course of a research study using the propensity score. We further describe 2 propensity score methods for evaluating the association of treatment or therapy with outcomes, propensity score matching and inverse probability of treatment weighting, and compare to covariate-adjusted regression analysis. We distinguish several estimators of treatment effect available with propensity score methods, including the average treatment effect, the average treatment effect for the treated, and average treatment effect for the controls or untreated, and compare to the conditional treatment effect in covariate-adjusted regression. We highlight the relative advantages of the various methods and estimators, describe analysis assumptions and how to critically evaluate them, and demonstrate methods in an analysis of thoracic epidural analgesia and new-onset atrial arrhythmias after pulmonary resection.
Biomechanical Comparison of Anatomic and Extra-Anatomic Reconstruction Techniques Using Local Grafts for Chronic Instability of the Acromioclavicular Joint
Thoreson, Andrew R. , Delgrande, Damien, Lafosse, Thibault , Werthel, Jean-David , Hardy, P., Elhassan, Bassem T. , Le Hanneur, Malo, Thoreson, Andrew, Elhassan, Bassem, Hanneur, Malo Le

Mayo Clinic

The American Journal of Sports Medicine | May 10, 2018 | Volume: 46 | Issue: 8 | Pages: 1927-1935

10.1177/0363546518770603 | PMID 29746150 Get It

Background: Anatomic reconstruction techniques are increasingly used to address cases of acromioclavicular (AC) joint chronic instability. These usually involve an additional surgical site for autograft harvesting or an allograft. Purpose: To describe a triple-bundle (TB) anatomic reconstruction using on-site autografts, the semiconjoint tendon (SCT) and the coracoacromial ligament (CAL), and compare its primary stability to the native AC joint ligamentous complex and to a modified Weaver-Dunn (WD) reconstruction. Study Design: Controlled laboratory study. Methods: Intact AC joints of 12 paired cadaveric shoulders were tested for anterior, posterior, and superior translations under cyclic loading with a servo-hydraulic testing system. One shoulder from each pair was randomly assigned to the TB group, where 2 SCT strips were used to reconstruct the coracoclavicular ligaments while the distal end of the CAL was transferred to the distal extremity of the clavicle to reconstruct the AC ligaments; the other shoulder received a modified WD reconstruction. After reconstruction, the same translational testing was performed, with an additional load-to-failure test in the superior direction. Results: In both the TB and the WD groups, no significant differences were found before and after reconstruction in terms of joint displacements after cyclic loading, in all 3 directions. Compared with the WD reconstruction, the TB repair resulted in significantly lower displacements in both the anterior (ie, 2.59 ± 1.08 mm, P = .011) and posterior (ie, 10.17 ± 6.24 mm, P = .014) directions, but not in the superior direction. No significant differences were observed between the 2 reconstructions during the load-to-failure testing, except for the displacement to failure, which was significantly smaller (ie, 5.34 ± 2.97 mm) in the WD group ( P = .037). Conclusion: Anterior, posterior, and superior displacements after an anatomic reconstruction of the AC joint complex using the SCT and CAL as graft material were similar to those of native AC joints and significantly smaller in the axial plane than those of AC joints after a WD repair. Clinical Relevance: An anatomic reconstruction is achievable using the CAL and the SCT as on-site graft materials, providing satisfactory initial stability and thereby allowing earlier mobilization.
Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine‐rich glioma‐inactivated protein 1
Feyissa, Anteneh M. , Lamb, Christopher J. , Pittock, Sean J. , Gadoth, Avi , McKeon, Andrew , Lamb, Christopher, Pittock, S J , Feyissa, A M , Lamb, Christopher J , McKeon, Andrew , Klein, Christopher J. , Britton, Jeffrey W.

Mayo Clinic

Epilepsia Open | May 10, 2018 | Volume: 3 | Issue: 3 | Pages: 348-356

10.1002/epi4.12226 | PMID 30187005 Get It

SummaryObjectiveTo characterize seizure semiology and the utility of antiepileptic drug (AED) therapy in leucine‐rich glioma inactivated‐1 ( LGI1‐Ab) autoimmune epilepsy (AE).MethodsPatients with voltage‐gated potassium channel complex (VGKCc) titers higher than 0.02 nmol/L who were evaluated between May 2008 and June 2016 at the 3 Mayo Clinic sites (Arizona, Florida, or Minnesota) were identified. We then performed a retrospective review of those who were LGI1‐Ab positive and were treated for seizures.ResultsA total of 1,095 patients with VGKCc titers higher than 0.02 nmol/L were identified, in which 77 were LGI1 positive. Of these, 56 patients with seizures were included in the analysis. Mean age at symptom onset was 62.9 years; 66% (n = 37) were male. The most common seizure semiology was focal faciobrachial dystonic seizures with preserved awareness (FBDS) (n = 35, 63%), followed by focal with impaired awareness (FIA) (n = 29, 52%), generalized tonic–clonic (GTCs) (n = 28, 50%), and focal non‐motor seizures with preserved awareness (n = 28, 50%). The majority had more than one seizure type (n = 49, 88%; median = 2.5). Thirty‐eight patients (68%) became seizure free: 29 (76%) with immunotherapy, 3 (5%) with AEDs alone, 2 (3%) with AEDs before any immunotherapy, and 4 (7%) with AEDs after immunotherapy. Levetiracetam (n = 47, 84%) and valproic acid (n = 21, 38%) were the most commonly used AEDs, but neither were associated with seizure freedom. Sodium channel blocking (NCB) AEDs were associated with seizure freedom in 4 patients compared to none treated with non‐NCB AEDs. Regardless of class, AEDs prior to or apart from immunotherapy were associated with seizure freedom in only five patients (9%). In patients with FBDS, seizure freedom was more often associated with immunotherapy than AEDs (20/30 vs. 3/34, p = 0.001).SignificanceAlthough FBDS are the most characteristic seizure type seen in LGI1‐Ab AE, other seizure types including FIA and GTCs also occur. Immunotherapy was the treatment most frequently associated with seizure freedom in LGI1‐Ab AE. In general, AEDs seemed to confer a very low chance for seizure freedom, although AEDs with NCB‐blocking properties were associated with seizure freedom in a limited number. Levetiracetam in particular appears to be ineffective in this patient population.